Tregs Differentially Suppress HIV-specific CD8+ T Cells
Tregs Differentially Suppress HIV-specific CD8+ T Cells
批准号:
8077329
负责人:
HELEN HORTON
金额:
$24.32万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2012-05-31
关键词:
Acquired Immunodeficiency SyndromeAllelesAutoimmune DiseasesAutoimmunityBiological AssayCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsCellular ImmunityChronicCleaved cellCyclic AMPCytokine GeneDataDiseaseDisease ProgressionEffector CellEnzymesEpitope MappingFunctional disorderGap JunctionsGene ExpressionGoalsHIVHIV InfectionsHIV-1HLA-B27 AntigenHLA-B57HumanImmune responseIndividualInfectionInfection ControlInfluenzaLeukapheresisLightMalignant NeoplasmsMediatingMediator of activation proteinOutcomePDE 3BPathway interactionsPhosphatidylinositolsPhosphotransferasesProliferatingProtein-Serine-Threonine KinasesRegulatory T-LymphocyteResistanceRoleSamplingT cell responseT-LymphocyteTherapeutic InterventionVirusVirus DiseasesWorkbasecytokinegranzyme Bkillingsmouse modelperipheral tolerancepublic health relevancereceptoruptake
中文摘要
描述(由申请人提供):CD8+ T细胞在细胞内感染(如HIV)的免疫应答中起关键作用。然而,在慢性感染期间,hiv特异性CD8+ T细胞变得耐受,因为它们不像来自其他非持续性病毒感染(如流感)的病毒特异性T细胞那样有效地增殖或杀死受感染的靶标。我们已经证明,受与非进展相关的HLA等位基因(HLA- b27 /-B57)限制的hiv特异性T细胞对这种外周耐受性具有抵抗力,这可能解释了为什么罕见的hiv感染者不会进展为艾滋病。导致hiv特异性CD8+ T细胞耐受的机制尚不清楚,但了解它们对于使治疗干预成为可能至关重要。调节性T细胞(Tregs)是外周耐受性的最佳介质之一。我们的初步数据表明,受HLA- b27 /-B57限制的hiv特异性T细胞对treg介导的增殖能力抑制具有抗性,而受其他HLA等位基因限制的hiv特异性T细胞对treg介导的抑制敏感。在这个提议中,我们的目标是破译Tregs如何引起hiv特异性T细胞的差异抑制。在Aim 1中,我们将确定抵抗Treg抑制的hiv特异性CD8+ T细胞在能够控制HIV-1的个体中是否是一种常见现象。在Aim 2中,我们将确定Tregs在慢性感染期间抑制hiv特异性T细胞反应的机制,以及受HLA-B27/B57限制的T细胞如何能够摆脱这种抑制。这项研究可以确定为什么某些HLA等位基因与hiv感染者的不进展有关。此外,如果我们确定特异性T细胞如何从Treg介导的抑制中逃脱,这项工作可能对其他慢性病毒感染、癌症和自身免疫性疾病的治疗干预具有深远的意义。
英文摘要
DESCRIPTION (provided by applicant): CD8+ T cells are key players in the immune response to intracellular infections such as HIV. However, during chronic infection HIV-specific CD8+ T cells become tolerant in that they do not proliferate or kill infected targets as efficiently as virus-specific T cells from other non-persistent viral infections (e.g. influenza). We have shown that HIV-specific T cells restricted by HLA alleles associated with non-progression (HLA-B27/-B57) are resistant to this type of peripheral tolerance, which may explain why rare HIV-infected individuals are protected from progression to AIDS. The mechanism(s) leading to HIV-specific CD8+ T cell tolerance are not known but understanding them is vital to making therapeutic intervention possible. Regulatory T cells (Tregs) are one of the best-described mediators of peripheral tolerance. Our preliminary data show that HIV-specific T cells restricted by HLA-B27/-B57 are resistant to Treg-mediated suppression of proliferative capacity whereas HIV-specific T cells restricted by other HLA alleles are susceptible to Treg-mediated suppression. In this proposal we aim to decipher how Tregs are causing differential suppression of HIV-specific T cells. In Aim 1, we will determine if HIV-specific CD8+ T cells that are resistant to Treg suppression are a common phenomenon in individuals who can control HIV-1. In Aim 2, we will determine which mechanism(s) are utilized by Tregs to suppress HIV-specific T cell responses during chronic infection and how T cells restricted by HLA-B27/B57 are able to escape from this suppression. This study could define why certain HLA alleles are associated with non- progression in HIV-infected individuals. In addition, if we define how specific T cells escape from Treg- mediated suppression this work could have far-reaching implications for therapeutic intervention in other chronic viral infections, cancer and autoimmune disease.
PUBLIC HEALTH RELEVANCE: This proposal aims to determine (1) whether HIV-specific T cells that escape Treg-mediated suppression are a common phenomenon in individuals who control HIV-1 infection; (2) the mechanisms utilized by Tregs to suppress HIV-specific T cell function; and (3) how HIV-specific HLA-B27/57-restricted T cells are able to escape Treg-mediated suppression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses
-
批准号:8298408
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2012
-
负责人:HELEN HORTON
-
依托单位:
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses
-
批准号:8446267
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2012
-
负责人:HELEN HORTON
-
依托单位:
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
-
批准号:8287662
-
项目类别:
-
资助金额:$56.97万
-
财政年份:2010
-
负责人:HELEN HORTON
-
依托单位:
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
-
批准号:8607346
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2010
-
负责人:HELEN HORTON
-
依托单位:
Tregs Differentially Suppress HIV-specific CD8+ T Cells
-
批准号:8012301
-
项目类别:
-
资助金额:$29.48万
-
财政年份:2010
-
负责人:HELEN HORTON
-
依托单位:
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
-
批准号:8081850
-
项目类别:
-
资助金额:$56.79万
-
财政年份:2010
-
负责人:HELEN HORTON
-
依托单位:
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
-
批准号:7989095
-
项目类别:
-
资助金额:$64.77万
-
财政年份:2010
-
负责人:HELEN HORTON
-
依托单位:
Activation-induced Non-responsiveness causes HIV Prog.
-
批准号:7089949
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2005
-
负责人:HELEN HORTON
-
依托单位:
Activation-induced Non-responsiveness causes HIV Prog.
-
批准号:7574710
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2005
-
负责人:HELEN HORTON
-
依托单位:
Activation-induced Non-responsiveness causes HIV Prog.
-
批准号:7610904
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2005
-
负责人:HELEN HORTON
-
依托单位:
Activation-induced Non-responsiveness causes HIV Prog.
-
批准号:7005770
-
项目类别:
-
资助金额:$28.03万
-
财政年份:2005
-
负责人:HELEN HORTON
-
依托单位:
Activation-induced Non-responsiveness causes HIV Prog.
-
批准号:7216846
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2005
-
负责人:HELEN HORTON
-
依托单位:
Activation-induced Non-responsiveness causes HIV Prog.
-
批准号:7390691
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2005
-
负责人:HELEN HORTON
-
依托单位:
海外基金